Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116496189B reveals copper-catalyzed synthesis of N-acyl sulfenamides. Enables efficient asymmetric disulfide production for ADCs and pharmaceutical intermediates with mild conditions.
Patent CN119874555A reveals a room-temperature, catalyst-free synthesis for beta-chloroenamides. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114014802A details a mild Pd-catalyzed route for enamides, offering cost reduction in fine chemical manufacturing and high-purity pharmaceutical intermediates.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.
Patent CN114014802A details a mild Pd-catalyzed dehydrogenative coupling for enamides, offering cost reduction in pharmaceutical intermediate manufacturing via scalable routes.
Patent CN108409615B discloses a green route for chiral sulfinamides, eliminating liquid ammonia usage and enhancing yield for reliable pharmaceutical intermediate supply chains.
Breakthrough palladium-catalyzed dehydrogenation coupling method enables high-yield enamide production with mild conditions, enhancing supply chain reliability for pharmaceutical intermediates.
Solve low-yield and harsh conditions in enamide synthesis. Our CDMO expertise scales this palladium-catalyzed method with 60-81% yields, reducing costs and supply chain risks for API manufacturing.
Avoid transition metal contamination in β-thiocyano-enamide synthesis. Our CDMO expertise enables scalable electrochemical production with >85% yield and open-system operation.
Discover how recent patent breakthroughs in metal-free catalysis for branched 1,4-dienamide synthesis can reduce production costs and improve supply chain stability for pharmaceutical intermediates.
Discover a scalable chiral ligand synthesis method with 80%+ yield, eliminating column chromatography to cut costs and environmental impact. Ideal for API manufacturing.